Notably, work from the same group showed that the expression of B7-H4 was a marker for immunosuppressive tumor-associated macrophages in ovarian carcinoma (162), and that the presence of Tregs and macrophage-associated B7-H4 at the tumor site was negatively associated with patient outcome (163, 164). This evidence concerns the gene VTCN1 and ovarian carcinoma.